Our forum is experiencing technical difficulties with comments being displayed. We apologize for the inconvience.

GCS Resources - Page 3 of 4 - The GCS Project

Diagnosis and Treatment with Dr. Marcela del Carmen (Part 7) [VIDEO]

Patient/advocate Diane Redington and Dr. Marcela del Carmen discuss diagnosis and treatment of gynecological carcinosarcoma (MMMT). This is part seven of a nine-part series. Dr. Marcela del Carmen discusses how gynecological carcinosarcoma is different than ovarian or uterine cancers. It is very important to get an accurate diagnosis from an expert to confirm exactly what […]

Posted: May 5, 2017 | View More »

Advocacy with GYN Carcinosarcoma (MMMT) with Dr. Marcela del Carmen (Part 8) [VIDEO]

Patient/advocate Diane Redington and Dr. Marcela del Carmen discuss the importance of clinical trials and the extreme lack of funding for gynecological cancer research. This is part eight of a nine-part series. Dr. Marcela del Carmen explains that the field is on the forefront of major discoveries in understanding the biology of this carcinosarcoma; however, […]

Posted: May 7, 2017 | View More »

Second Opinions for GYN Carcinosarcoma (MMMT) with Dr. Marcela del Carmen (Part 9) [VIDEO]

Patient/advocate Diane Redington and Dr. Marcela del Carmen discuss the importance of being armed with as much information as possible in fighting gynecological carcinosarcoma. This is the ninth video of our nine-part series.   Dr. Marcela del Carmen explains that patients live longer when being treated by doctors that are true experts in GYN carcinosarcoma […]

Posted: May 9, 2017 | View More »

Knowledge truly is power – and part of our mission is to provide the correct information about gynecologic carcinosarcoma (GCS), also known as malignant mixed Müllerian tumor (MMMT).   Visit our “WHAT IS GCS / MMMT?” page to read more details about this type of cancer and it’s treatment options. Click Here   Message from Diane: […]

Posted: November 13, 2017 | View More »

The GCS Project is a 501c3 Organization

(updated 1/27/18) The GCS Project has received approval from the IRS to become a 501(c)(3)!    Why is it important for The GCS Project to become a 501c3?    Obtaining 501c3 status enables the GCS Project to become eligible for grants and other public and private allocations available only to IRS-recognized,501(c)(3) organizations. In addition, when and organization has obtained […]

Posted: August 8, 2017 | View More »

Thank You Kevin! $5500 Raised for GCS

  On May 7th, Kevin Schieferstein ran the Pittsburgh Marathon to raise money for the GCS Project. He raised $5500! Kevin, we cannot thank you enough for your support. What an amazing run!  

Posted: May 11, 2017 | View More »

Newly Diagnosed? What to do

SIX STEPS TO TAKE WHEN YOU ARE DIAGNOSED WITH MMMT OR CARCINOSARCOMA By Diane Redington   You have just received a traumatic diagnosis of one of the rare gynecological carcinosarcomas. It could be ovarian, uterine or more rare—tubal or vaginal. Internet research indicates, “MMMT is a very rare and aggressive cancer with a poor prognosis.” […]

Posted: December 22, 2017 | View More »

Clinical Trials

 We see some clinical trials in the future: The major research being performed at the Broad Institute (Broad Institute Link – Click Here) in Boston is scheduled to be completed in the next 8-12 weeks. Once the data is collected, data analysis will take another 4-6 weeks. The analysis of the data will yield potential targets for […]

Posted: October 2, 2017 | View More »


Hello everyone – There is important and new GCS treatment information posted on our Forum. Please click this link and share comments there!

Posted: September 14, 2017 | View More »

The Battle Against Carcinosarcoma 

An interview with Sam Stern – fighter, thinker, and survivor Sam Stern has done many things. She was an accomplished criminal prosecutor, was and continues to be a practicing Buddhist and Vipassana meditation teacher, she’s the mother to two beautiful children, aged 16 and 20, and she was a mindfulness and pain management teacher to […]

Posted: January 16, 2017 | View More »